Vbi Vaccines Stock Price To Earning
VBI Vaccines fundamentals help investors to digest information that contributes to VBI Vaccines' financial success or failures. It also enables traders to predict the movement of VBI Stock. The fundamental analysis module provides a way to measure VBI Vaccines' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to VBI Vaccines stock.
VBI |
VBI Vaccines Company Price To Earning Analysis
VBI Vaccines' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current VBI Vaccines Price To Earning | (3.79) X |
Most of VBI Vaccines' fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, VBI Vaccines is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
CompetitionBased on the latest financial disclosure, VBI Vaccines has a Price To Earning of -3.79 times. This is 114.67% lower than that of the Biotechnology sector and 176.88% lower than that of the Health Care industry. The price to earning for all United States stocks is 113.2% higher than that of the company.
VBI Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses VBI Vaccines' direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of VBI Vaccines could also be used in its relative valuation, which is a method of valuing VBI Vaccines by comparing valuation metrics of similar companies.VBI Vaccines is currently under evaluation in price to earning category among its peers.
VBI Fundamentals
Return On Equity | -4.2 | |||
Return On Asset | -0.29 | |||
Operating Margin | (9.68) % | |||
Current Valuation | 38.92 M | |||
Shares Outstanding | 28.68 M | |||
Shares Owned By Insiders | 6.76 % | |||
Shares Owned By Institutions | 13.00 % | |||
Number Of Shares Shorted | 276.87 K | |||
Price To Earning | (3.79) X | |||
Price To Book | 1.24 X | |||
Price To Sales | 0.20 X | |||
Revenue | 8.68 M | |||
Gross Profit | (10.19 M) | |||
EBITDA | (53.32 M) | |||
Net Income | (92.84 M) | |||
Cash And Equivalents | 82.41 M | |||
Cash Per Share | 0.32 X | |||
Total Debt | 53.04 M | |||
Debt To Equity | 0.32 % | |||
Current Ratio | 2.29 X | |||
Book Value Per Share | (0.22) X | |||
Cash Flow From Operations | (60.88 M) | |||
Short Ratio | 1.57 X | |||
Earnings Per Share | (3.54) X | |||
Target Price | 5.0 | |||
Number Of Employees | 131 | |||
Beta | 2.17 | |||
Market Capitalization | 1.87 M | |||
Total Asset | 86.95 M | |||
Retained Earnings | (582.45 M) | |||
Working Capital | (39.51 M) | |||
Current Asset | 7.89 M | |||
Current Liabilities | 3.03 M | |||
Net Asset | 86.95 M |
About VBI Vaccines Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze VBI Vaccines's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VBI Vaccines using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VBI Vaccines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in VBI Stock
If you are still planning to invest in VBI Vaccines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VBI Vaccines' history and understand the potential risks before investing.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |